Diamond Therapeutics

Private

TorontoHealthcare & Life Scienceshttps://www.diamondthera.com/

Last Round

Grant

May 11, 2026

Total Funding Raised

$8.55M

Company Overview

Diamond Therapeutics is a biotechnology company that develops sub-perceptual, non-hallucinogenic psychedelic-based medicines for the treatment of mental health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

psychedelic medicinepsilocybin therapynon-hallucinogenicneuroplastogensmental health treatmentbiotechnologydrug discoverysub-perceptualclinical trialstryptamine analogsmicrodosingpsychedelic biotechtake-at-home therapyneuropsychiatric disorderssmall molecule drugs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Diamond Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Diamond Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Diamond Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 11, 2026
Seed	Apr 4, 2023
Convertible Debt	Jan 7, 2021
Seed	Apr 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Judy Blumstock

Founder & CEO

Founding Team

Grant McCutcheon

Chief Financial Officer

Executive Team

Diamond Therapeutics Investors

Notable investors and investment history

Diamond Therapeutics investors
Investor	Rounds
Ontario Brain Institute	Convertible Debt
ARPA-H	Grant

View all Investors

Diamond Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Diamond Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Diamond Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto

Employee Range8

Year Founded2018

Last FundingMay 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.